Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease
<p>Abstract</p> <p>Background</p> <p>The long-term efficacy and safety of aclidinium bromide, a novel, long-acting muscarinic antagonist, were investigated in patients with moderate to severe chronic obstructive pulmonary disease (COPD).</p> <p>Methods</p...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-04-01
|
| Series: | Respiratory Research |
| Subjects: | |
| Online Access: | http://respiratory-research.com/content/12/1/55 |